Doximity (NASDAQ:DOCS) Given New $43.00 Price Target at Wells Fargo & Company

Doximity (NASDAQ:DOCS) had its price objective boosted by research analysts at Wells Fargo & Company from $41.00 to $43.00 in a note issued to investors on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective points to a potential downside of 15.15% from the stock’s current price.

Several other research firms have also weighed in on DOCS. Mizuho started coverage on Doximity in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $55.00 price objective for the company. Canaccord Genuity Group reissued a “hold” rating and issued a $60.00 price objective (up from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. KeyCorp lowered their price objective on Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. Barclays lifted their price objective on Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research report on Monday, November 11th. Finally, The Goldman Sachs Group initiated coverage on Doximity in a research report on Friday, November 15th. They issued a “neutral” rating and a $58.00 target price for the company. Thirteen analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $53.12.

Doximity Trading Up 2.0 %

Shares of DOCS opened at $50.68 on Monday. The company has a market capitalization of $9.46 billion, a PE ratio of 58.25, a PEG ratio of 4.13 and a beta of 1.38. Doximity has a 12 month low of $22.96 and a 12 month high of $61.75. The stock’s 50-day moving average price is $53.40 and its two-hundred day moving average price is $42.09.

Institutional Trading of Doximity

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC boosted its stake in shares of Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after buying an additional 603 shares during the last quarter. Quarry LP boosted its stake in shares of Doximity by 101.2% in the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock worth $45,000 after buying an additional 131,253 shares during the last quarter. Morse Asset Management Inc purchased a new position in shares of Doximity in the 3rd quarter worth approximately $46,000. GAMMA Investing LLC boosted its stake in shares of Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares during the last quarter. Finally, Covestor Ltd boosted its stake in shares of Doximity by 441.9% in the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company’s stock worth $73,000 after buying an additional 1,370 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.